Flagged to be so much more than pictures of apes, artificial intelligence company Crowd Media (ASX: CM8) is set to launch a world first collection of interactive NFTs that will integrate their conversational AI technology. Confirmation of the NFT collections comes as Crowd Media entered into a Binding Heads of Agreement with California-based Web3 company
Read More
Australia’s renewable energy company MPower (ASX: MPR) has continued to accelerate growth, with them announcing that they’ve entered a Share Purchase Agreement with Kawa Australia Developments Pty Ltd to acquire the Lakeland Solar & Storage Project which is located in Cooktown Shire, North Queensland. The transaction will be worth $8m – with the Project expected
Read More
Gambling in China – it’s a big no no. But with the underground industry hugely lucrative in the mainland, many businesses are finding more legal means to monetise the gambling psyche within the Chinese population with sports tech company SportsHero (ASX: SHO) the latest to join the movement through the eSports predictor competitions. Just because
Read More
Ever wondered if your brother is really your brother? Or what breeds make up your dog (who was advertised by the rescue as ‘mixed breed blend’, I kid you not)? DNA testing has all the answers you seek, and with the technology becoming cheaper and scalable, direct-to-consumer DNA testing kits are now readily available. Leaders
Read More
Amid the many inconveniences caused by COVID over the past two years, the little discussed frustration is the sheer cost that organisations have spent to minimise outbreaks. However, for aged care operator Regis Healthcare (ASX: REG), the bill for Omicron has come to $14 million which they hope to get back. Given their stringent Government-imposed
Read More
When it comes to investing in publicly listed companies, there is no stronger show of confidence for shareholders than when Executive management buys shares on-market. It’s why investors should be taking note of one ASX-listed small cap CEO having bought $750k on-market in the past 2 years – a genuine indicator that they think the
Read More
It’s not up for debate- a woman’s body is her own. And yet, lots of people have lots to say about women’s bodies and what they should and shouldn’t be able to do. With the abortion debate at boiling point in America following a major backwards step in legislation, the rights of women are yet
Read More
Just 9 months since billionaire investor Tony Fung stood down as the Chairman of Aquis Entertainment (ASX: AQS), the company is packing up via the sale of Canberra Casino as the business has continued to struggle without the stewardship of Fung, their largest shareholder. Well known for his massive investment across Australia over the past
Read More
The ASX blockchain-based replacement for its clearing and settlement system CHESS has been delayed yet again this week for the fourth time. The major project undertaken by the ASX five years ago is still showing no signs of completion. Followed by delay after delay – it appears that this is one of the longest and
Read More
Rhythm Biosciences (ASX: RHY) is a step closer to commercialising their bowel cancer detection test, having submitted documents to the Australian Therapeutic Goods Administration (TGA) for approval. The filing is a significant milestone for the Company who are hoping to launch their product to market later this year. Rhythm’s test offers a convenient and non-invasive
Read More
